{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T02:41:23Z","timestamp":1789872083254,"version":"4.0.1"},"reference-count":62,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"2","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trans. Vis. Sci. Tech."],"published-print":{"date-parts":[[2026,2,12]]},"DOI":"10.1167\/tvst.15.2.16","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:30:44Z","timestamp":1770906644000},"page":"16","source":"Crossref","is-referenced-by-count":1,"title":["A Highly Active Angiopoietin 1 Mimetic Potentiates Angiogenesis in Mouse Models of Choroidal Neovascularization"],"prefix":"10.1167","volume":"15","author":[{"given":"Asmaa A.","family":"Youssif","sequence":"first","affiliation":[{"name":"Feinberg Cardiovascular and Renal Research Inst. Northwestern University Feinberg School of Medicine, Chicago, IL, USA"},{"name":"Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA"},{"name":"Department of Ophthalmology, Assiut University Faculty of Medicine, Assiut, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Liu","sequence":"additional","affiliation":[{"name":"Feinberg Cardiovascular and Renal Research Inst. Northwestern University Feinberg School of Medicine, Chicago, IL, USA"},{"name":"Section of Nephrology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danille","family":"Gaczkowski","sequence":"additional","affiliation":[{"name":"Feinberg Cardiovascular and Renal Research Inst. Northwestern University Feinberg School of Medicine, Chicago, IL, USA"},{"name":"Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Quaggin","sequence":"additional","affiliation":[{"name":"Feinberg Cardiovascular and Renal Research Inst. Northwestern University Feinberg School of Medicine, Chicago, IL, USA"},{"name":"Section of Nephrology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jin","sequence":"additional","affiliation":[{"name":"Feinberg Cardiovascular and Renal Research Inst. Northwestern University Feinberg School of Medicine, Chicago, IL, USA"},{"name":"Section of Nephrology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin R.","family":"Thomson","sequence":"additional","affiliation":[{"name":"Feinberg Cardiovascular and Renal Research Inst. Northwestern University Feinberg School of Medicine, Chicago, IL, USA"},{"name":"Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA"},{"name":"Department of Biomedical Engineering, Northwestern University, Evanston IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1172\/JCI42437","article-title":"Therapeutic targets in age-related macular disease","volume":"120","author":"Bird","year":"2010","journal-title":"J Clin Invest"},{"key":"bib3","doi-asserted-by":"crossref","first-page":"e1569","DOI":"10.1111\/aos.15137","article-title":"Incidence, risk factors and outcomes of submacular haemorrhage with loss of vision in neovascular age-related macular degeneration in daily clinical practice: data from the FRB! registry","volume":"100","author":"Gabrielle","year":"2022","journal-title":"Acta Ophthalmol"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.oret.2019.05.017","article-title":"Visual acuity outcomes and anti\u2013vascular endothelial growth factor therapy intensity in neovascular age-related macular degeneration patients: a real-world analysis of 49?485 eyes","volume":"4","author":"Ciulla","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"100906","DOI":"10.1016\/j.preteyeres.2020.100906","article-title":"Incomplete response to Anti-VEGF therapy in neovascular AMD: Exploring disease mechanisms and therapeutic opportunities","volume":"82","author":"Mettu","year":"2021","journal-title":"Prog Retin Eye Res"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/nrm2639","article-title":"Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system","volume":"10","author":"Augustin","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/s41433-020-01377-x","article-title":"Angiopoietin\/Tie2 signalling and its role in retinal and choroidal vascular diseases: a review of preclinical data","volume":"35","author":"Joussen","year":"2021","journal-title":"Eye"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1681\/ASN.2017090962","article-title":"Ascending vasa recta are angiopoietin\/Tie2-dependent lymphatic-like vessels","volume":"29","author":"Kenig-Kozlovsky","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1073\/pnas.1714446115","article-title":"Context-dependent functions of angiopoietin 2 are determined by the endothelial phosphatase VEPTP","volume":"115","author":"Souma","year":"2018","journal-title":"Proc Natl Acad Sci"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S1534-5807(02)00217-4","article-title":"Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by angiopoietin-1","volume":"3","author":"Gale","year":"2002","journal-title":"Dev Cell"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"4320","DOI":"10.1172\/JCI77162","article-title":"A lymphatic defect causes ocular hypertension and glaucoma in mice","volume":"124","author":"Thomson","year":"2014","journal-title":"J Clin Invest"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1172\/JCI85830","article-title":"Angiopoietin receptor TEK mutations underlie primary congenital glaucoma with variable expressivity","volume":"126","author":"Souma","year":"2016","journal-title":"J Clin Invest"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.1172\/JCI95545","article-title":"Angiopoietin-1 is required for Schlemm's canal development in mice and humans","volume":"127","author":"Thomson","year":"2017","journal-title":"J Clin Invest"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1161\/ATVBAHA.122.318151","article-title":"Angiopoietin-1 is required for vortex vein and choriocapillaris development in mice","volume":"42","author":"Liu","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1101\/gad.8.16.1897","article-title":"Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo","volume":"8","author":"Dumont","year":"1994","journal-title":"Genes Dev"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.2337\/diabetes.53.4.1104","article-title":"Angiopoietin-2 causes pericyte dropout in the normal retina: evidence for involvement in diabetic retinopathy","volume":"53","author":"Hammes","year":"2004","journal-title":"Diabetes"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/S0092-8674(00)81813-9","article-title":"Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis","volume":"87","author":"Suri","year":"1996","journal-title":"Cell"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nrd.2016.278","article-title":"Therapeutic targeting of the angiopoietin-TIE pathway","volume":"16","author":"Saharinen","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.15252\/emmm.201505889","article-title":"Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases","volume":"8","author":"Regula","year":"2016","journal-title":"EMBO Mol Med"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1371\/journal.pmed.0030046","article-title":"Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans","volume":"3","author":"Parikh","year":"2006","journal-title":"PLoS Med"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1126\/science.277.5322.55","article-title":"Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis","volume":"277","author":"Maisonpierre","year":"1997","journal-title":"Science"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/sj.gt.3302230","article-title":"Angiopoietin 1 inhibits ocular neovascularization and breakdown of the blood\u2013retinal barrier","volume":"11","author":"Nambu","year":"2004","journal-title":"Gene Ther"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1167\/iovs.14-13897","article-title":"Angiopoietin-1 suppresses choroidal neovascularization and vascular leakage","volume":"55","author":"Lee","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"e10204","DOI":"10.15252\/emmm.201810204","article-title":"Efficacy of simultaneous VEGF-A\/ANG-2 neutralization in suppressing spontaneous choroidal neovascularization","volume":"11","author":"Foxton","year":"2019","journal-title":"EMBO Mol Med"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"4564","DOI":"10.1172\/JCI74527","article-title":"Targeting VE-PTP activates TIE2 and stabilizes the ocular vasculature","volume":"124","author":"Shen","year":"2014","journal-title":"J Clin Invest"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"5547","DOI":"10.1073\/pnas.0307574101","article-title":"COMP-Ang1: a designed angiopoietin-1 variant with nonleaky angiogenic activity","volume":"101","author":"Cho","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nsb880","article-title":"Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclustering","volume":"10","author":"Davis","year":"2003","journal-title":"Nat Struct Biol"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"15291","DOI":"10.1038\/srep15291","article-title":"A designed angiopoietin-1 variant, dimeric CMP-Ang1 activates Tie2 and stimulates angiogenesis and vascular stabilization in N-glycan dependent manner","volume":"5","author":"Oh","year":"2015","journal-title":"Sci Rep"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.sbi.2008.04.008","article-title":"Structural specificity in coiled-coil interactions","volume":"18","author":"Grigoryan","year":"2008","journal-title":"Curr Opin Struct Biol"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1161\/01.RES.0000174093.64855.a6","article-title":"Long-term and sustained COMP-Ang1 induces long-lasting vascular enlargement and enhanced blood flow","volume":"97","author":"Cho","year":"2005","journal-title":"Circ Res"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"1192464","DOI":"10.3389\/fncel.2023.1192464","article-title":"Delineating effects of angiopoietin-2 inhibition on vascular permeability and inflammation in models of retinal neovascularization and ischemia\/reperfusion","volume":"17","author":"Canonica","year":"2023","journal-title":"Front Cell Neurosci"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"eaau6732","DOI":"10.1126\/sciadv.aau6732","article-title":"Tie2 activation promotes choriocapillary regeneration for alleviating neovascular age-related macular degeneration","volume":"5","author":"Kim","year":"2019","journal-title":"Sci Adv"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S0140-6736(22)00010-1","article-title":"Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials","volume":"399","author":"Heier","year":"2022","journal-title":"Lancet"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.ophtha.2024.02.014","article-title":"TENAYA and LUCERNE: two-year results from the phase 3 neovascular age-related macular degeneration trials of faricimab with treat-and-extend dosing in year 2","volume":"131","author":"Khanani","year":"2024","journal-title":"Ophthalmology"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.1172\/JCI84871","article-title":"Opposing actions of angiopoietin-2 on Tie2 signaling and FOXO1 activation","volume":"126","author":"Kim","year":"2016","journal-title":"J Clin Invest"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.2353\/ajpath.2009.090391","article-title":"Contrasting actions of selective inhibitors of angiopoietin-1 and angiopoietin-2 on the normalization of tumor blood vessels","volume":"175","author":"Falc\u00f3n","year":"2009","journal-title":"Am J Pathol"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"15296","DOI":"10.1038\/ncomms15296","article-title":"Plastic roles of pericytes in the blood\u2013retinal barrier","volume":"8","author":"Park","year":"2017","journal-title":"Nat Commun"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1158\/0008-5472.CAN-12-2064","article-title":"Angiopoietin-2 functions as a Tie2 agonist in tumor models, where it limits the effects of VEGF inhibition","volume":"73","author":"Daly","year":"2013","journal-title":"Cancer Res"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/bit.27580","article-title":"New soluble angiopoietin analog of Hepta-ANG1 prevents pathological vascular leakage","volume":"118","author":"Liu","year":"2021","journal-title":"Biotechnol Bioeng"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"6072","DOI":"10.1038\/s41467-021-26346-0","article-title":"Cellular crosstalk regulates the aqueous humor outflow pathway and provides new targets for glaucoma therapies","volume":"12","author":"Thomson","year":"2021","journal-title":"Nat Commun"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1681\/ASN.0000000000000098","article-title":"Activation of angiopoietin-Tie2 signaling protects the kidney from ischemic injury by modulation of endothelial-specific pathways","volume":"34","author":"Li","year":"2023","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"bib43","doi-asserted-by":"publisher","first-page":"e176577","DOI":"10.1172\/JCI176577","article-title":"The mechanosensory channel PIEZO1 functions upstream of angiopoietin\/TIE\/FOXO1 signaling in lymphatic development","volume":"134","author":"Du","year":"2024","journal-title":"J Clin Invest"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Meth"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1001\/archopht.120.3.338","article-title":"Prevention of experimental choroidal neovascularization with intravitreal anti\u2013vascular endothelial growth factor antibody fragment","volume":"120","author":"Krzystolik","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"bib46","first-page":"3158","article-title":"VEGF is major stimulator in model of choroidal neovascularization","volume":"41","author":"Kwak","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1007\/s00417-011-1699-4","article-title":"Monocyte\/macrophages promote vasculogenesis in choroidal neovascularization in mice by stimulating SDF-1 expression in RPE cells","volume":"249","author":"Shi","year":"2011","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"bib48","doi-asserted-by":"publisher","first-page":"5127","DOI":"10.1167\/iovs.18-25046","article-title":"Spontaneous posterior segment vascular disease phenotype of a mouse model, rnv3, is dependent on the Crb1rd8 allele","volume":"59","author":"Chang","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1167\/iovs.14-13989","article-title":"Spontaneous CNV in a novel mutant mouse is associated with early VEGF-A-driven angiogenesis and late-stage focal edema, neural cell loss, and dysfunction","volume":"55","author":"Nagai","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib50","doi-asserted-by":"publisher","first-page":"e21032","DOI":"10.7554\/eLife.21032","article-title":"Angiopoietin receptor Tie2 is required for vein specification and maintenance via regulating COUP-TFII","volume":"5","author":"Chu","year":"2016","journal-title":"eLife"},{"key":"bib51","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1101\/gad.1189704","article-title":"Angiopoietin-1 modulates endothelial cell function and gene expression via the transcription factor FKHR (FOXO1)","volume":"18","author":"Daly","year":"2004","journal-title":"Genes Dev"},{"key":"bib52","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1161\/01.RES.86.1.24","article-title":"Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-kinase\/Akt signal transduction pathway","volume":"86","author":"Kim","year":"2000","journal-title":"Circ Res"},{"key":"bib53","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nature16498","article-title":"FOXO1 couples metabolic activity and growth state in the vascular endothelium","volume":"529","author":"Wilhelm","year":"2016","journal-title":"Nature"},{"key":"bib54","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1172\/JCI23126","article-title":"Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization","volume":"115","author":"Potente","year":"2005","journal-title":"J Clin Invest"},{"key":"bib55","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1161\/01.RES.83.3.233","article-title":"Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization","volume":"83","author":"Asahara","year":"1998","journal-title":"Circ Res"},{"key":"bib56","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S0002-9440(10)64242-3","article-title":"Regulation of angiogenesis by vascular endothelial growth factor and angiopoietin-1 in the rat aorta model: distinct temporal patterns of intracellular signaling correlate with induction of angiogenic sprouting","volume":"161","author":"Zhu","year":"2002","journal-title":"Am J Pathol"},{"key":"bib57","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1172\/JCI119740","article-title":"Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth","volume":"100","author":"Lin","year":"1997","journal-title":"J Clin Invest"},{"key":"bib58","doi-asserted-by":"publisher","first-page":"4946","DOI":"10.1073\/pnas.0506352103","article-title":"COMP-angiopoietin-1 promotes wound healing through enhanced angiogenesis, lymphangiogenesis, and blood flow in a diabetic mouse model","volume":"103","author":"Cho","year":"2006","journal-title":"Proc Natl Acad Sci"},{"key":"bib59","doi-asserted-by":"publisher","first-page":"5547","DOI":"10.1073\/pnas.0307574101","article-title":"COMP-Ang1: a designed angiopoietin-1 variant with nonleaky angiogenic activity","volume":"101","author":"Cho","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"bib60","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.exer.2016.01.009","article-title":"Subretinal AAV2.COMP-Ang1 suppresses choroidal neovascularization and vascular endothelial growth factor in a murine model of age-related macular degeneration","volume":"145","author":"Lambert","year":"2016","journal-title":"Exp Eye Res"},{"key":"bib61","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1172\/JCI58832","article-title":"Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling","volume":"122","author":"Felcht","year":"2012","journal-title":"J Clin Invest"},{"key":"bib62","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1158\/1535-7163.MCT-10-0213","article-title":"Context-dependent role of angiopoietin-1 inhibition in the suppression of angiogenesis and tumor growth: implications for AMG 386, an angiopoietin-1\/2\u2013neutralizing peptibody","volume":"9","author":"Coxon","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"bib2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/978-3-642-22107-1_6","article-title":"Early AMD","volume-title":"Age-related Macular Degeneration","author":"Dietzel","year":"2013"},{"key":"bib30","first-page":"197","article-title":"Chapter Six - Molecular basis of laminin\u2013integrin interactions","volume-title":"Current Topics in Membranes","author":"Yamada","year":"2015"}],"container-title":["Translational Vision Science & Technology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/tvst.arvojournals.org\/article.aspx?doi=10.1167\/tvst.15.2.16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:30:45Z","timestamp":1770906645000},"score":1,"resource":{"primary":{"URL":"http:\/\/tvst.arvojournals.org\/article.aspx?doi=10.1167\/tvst.15.2.16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,2]]}},"URL":"https:\/\/doi.org\/10.1167\/tvst.15.2.16","relation":{},"ISSN":["2164-2591"],"issn-type":[{"value":"2164-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,12]]}}}